NR546 Psychopharmacology: Week 1
Study online at https://quizlet.com/_fxh2rd
1. What is the global burden of 30%
disease of mental health, neu-
rological, and substance use
disorders?
2. How many children and ado- 20%
lescents are impacted by men-
tal health disorders world-
wide?
3. How much does lost produc- $1 trillion USD
tivity related to anxiety and
depression cost the global
economy each year?
4. When prescribing medica- - symptoms
tions, the psychiatric men- - age
tal health nurse practitioner - physical health
(PMHNP) must consider each - previous response to treatment
client's unique circumstances - lifestyle
including but not limited to-
5. The development of mental - genetics
health conditions is linked to - biochemical processes
causes such as- - environment
- lifestyle
6. Which is the priority data used c. patient symptoms
to determine a treatment plan
for mental health disorders?
a. drug adverse effects
b. patient lifestyle
, NR546 Psychopharmacology: Week 1
Study online at https://quizlet.com/_fxh2rd
c. patient symptoms
d. treatment history
7. Psychoactive Medications (im-
age)
8. Psychoactive & Psychotropic According to the World Health Organization (WHO, 2020), the
Medications terms "psychoactive" and "psychotropic" may be used inter-
changeably and are the most neutral and descriptive terms for
medications that affect mental processes.
9. Symptom-Based Treatment - A diagnosis is determined based on the presenting symptoms
and by utilizing well-developed interview techniques and as-
sessment skills.
- The PMHNP must recognize that presenting symptoms may
represent what is happening within the client's brain. For ex-
ample, changes or losses in grey matter are associated with
numerous psychiatric diagnoses, including Alzheimer's disease,
schizophrenia, and major depressive disorder
10. Challenges of Psychiatric Pre- - Several factors hinder the effectiveness of psychiatric drugs
scribing making a one-size-fits-all treatment plan impossible and even
harmful. It is important to thoroughly understand the full scope
of a client's presenting symptoms.
- For example, a client who presents with depressive symptoms
such as a lack of energy, somnolence, weight loss, and suicidal
thinking may warrant treatment with a more stimulating antide-
pressant. On the contrary, a client who presents with both de-
pressive and anxiety symptoms together may require a different
medication that will not aggravate their anxiety. Even though
Study online at https://quizlet.com/_fxh2rd
1. What is the global burden of 30%
disease of mental health, neu-
rological, and substance use
disorders?
2. How many children and ado- 20%
lescents are impacted by men-
tal health disorders world-
wide?
3. How much does lost produc- $1 trillion USD
tivity related to anxiety and
depression cost the global
economy each year?
4. When prescribing medica- - symptoms
tions, the psychiatric men- - age
tal health nurse practitioner - physical health
(PMHNP) must consider each - previous response to treatment
client's unique circumstances - lifestyle
including but not limited to-
5. The development of mental - genetics
health conditions is linked to - biochemical processes
causes such as- - environment
- lifestyle
6. Which is the priority data used c. patient symptoms
to determine a treatment plan
for mental health disorders?
a. drug adverse effects
b. patient lifestyle
, NR546 Psychopharmacology: Week 1
Study online at https://quizlet.com/_fxh2rd
c. patient symptoms
d. treatment history
7. Psychoactive Medications (im-
age)
8. Psychoactive & Psychotropic According to the World Health Organization (WHO, 2020), the
Medications terms "psychoactive" and "psychotropic" may be used inter-
changeably and are the most neutral and descriptive terms for
medications that affect mental processes.
9. Symptom-Based Treatment - A diagnosis is determined based on the presenting symptoms
and by utilizing well-developed interview techniques and as-
sessment skills.
- The PMHNP must recognize that presenting symptoms may
represent what is happening within the client's brain. For ex-
ample, changes or losses in grey matter are associated with
numerous psychiatric diagnoses, including Alzheimer's disease,
schizophrenia, and major depressive disorder
10. Challenges of Psychiatric Pre- - Several factors hinder the effectiveness of psychiatric drugs
scribing making a one-size-fits-all treatment plan impossible and even
harmful. It is important to thoroughly understand the full scope
of a client's presenting symptoms.
- For example, a client who presents with depressive symptoms
such as a lack of energy, somnolence, weight loss, and suicidal
thinking may warrant treatment with a more stimulating antide-
pressant. On the contrary, a client who presents with both de-
pressive and anxiety symptoms together may require a different
medication that will not aggravate their anxiety. Even though
